Champions Oncology Files 8-K on Financials

Ticker: CSBR · Form: 8-K · Filed: Mar 11, 2025 · CIK: 771856

Champions Oncology, INC. 8-K Filing Summary
FieldDetail
CompanyChampions Oncology, INC. (CSBR)
Form Type8-K
Filed DateMar 11, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, exhibits

TL;DR

Champions Oncology dropped an 8-K on March 11th detailing their financials. Check it out.

AI Summary

Champions Oncology, Inc. filed an 8-K on March 11, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Champions Biotechnology, Inc. and International Group Inc.

Why It Matters

This 8-K filing provides an update on Champions Oncology's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Champions Oncology, Inc., and to include Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 11, 2025.

What was Champions Oncology, Inc. formerly known as?

Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and International Group Inc.

In which state is Champions Oncology, Inc. incorporated?

Champions Oncology, Inc. is incorporated in Delaware.

What is the business address of Champions Oncology, Inc.?

The business address of Champions Oncology, Inc. is 855 N. Wolfe Street, Suite 619, Baltimore, MD 21205.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding CHAMPIONS ONCOLOGY, INC. (CSBR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing